FDA Adverse Event Malfunction Summary report: N

ALBUMIN BCG METHOD

MDR report key: 2143296 · Received June 29, 2011

Report

Report Number
1823260-2011-03505
Event Type
Malfunction
Date Received
June 29, 2011
Date of Event
June 16, 2011
Report Date
June 28, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CIX
PMA / PMN Number
K033009
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Description of Event or Problem · 1

THE USER RECEIVED QUESTIONABLE ALBUMIN RESULTS FROM THE ANALYTICAL D MODULE ANALYZER SERIAL NUMBER (B)(4) THAT WERE DISCOVERED WHEN THEY WERE COMPARED TO THE PATIENT'S PREVIOUS RESULTS. THE USER STATED THEY HAD TO CORRECT RESULTS FOR ABOUT 20 PATIENT SAMPLES. HOWEVER, SPECIFIC DATA WAS PROVIDED FOR ONLY ONE PATIENT SAMPLE. THE INITIAL RESULT WAS 2.1 G/DL AND WAS REPORTED OUTSIDE THE LABORATORY. THE REPEAT RESULT WAS 3.5 G/DL. THE PATIENTS WERE NOT ADVERSELY AFFECTED. THE ALBUMIN R2 REAGENT LOT NUMBER WAS 63700201. UPON EVALUATION OF THE ANALYZER, THE FIELD SERVICE REPRESENTATIVE FOUND A PARTIALLY CLOTTED SAMPLE PROBE AND STYLETTED ALL FOUR SAMPLE PROBES. TO VERIFY THE ANALYZER OPERATION, HE PERFORMED PRECISION CHECKS WITH ALL RESULTS WITHIN SPECIFICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ALBUMIN BCG METHOD BROMCRESOL GREEN DYE-BINDING, ALBUMIN CIX ROCHE DIAGNOSTICS NA 63632101

Patients

Seq Age Sex Outcome Treatment
1